Literature DB >> 11283419

In vitro evaluation of intravascular stent artifacts in three-dimensional MR angiography.

D Maintz1, H Kugel, F Schellhammer, P Landwehr.   

Abstract

RATIONALE AND
OBJECTIVES: To evaluate the intraluminal signal characteristics of various stents and stent-grafts in contrast-enhanced three-dimensional MR angiography (3D MRA) in vitro.
METHODS: Fourteen stents made of different materials (steel, nitinol, tantalum, cobalt-based alloy, polyethylene) and six stent-grafts were implanted in plastic tubes simulating the common iliac artery. The tubes were filled with gadopentetate dimeglumine in water at a concentration of 25 mmol/L and positioned in a plastic container filled with water. For imaging, the container was placed in the center of the magnet, parallel, orthogonal, and diagonal to the z axis. A 3D gradient-echo sequence (T1-FFE) was acquired with the following parameters: repetition time 5.3 ms, echo time 1.6 ms, flip angle 50 degrees, slice thickness 1.5 mm, and acquisition matrix 256 with zero filling to 512. To evaluate the influence of the frequency-encoding gradient on the appearance of the artifacts, stents were examined with their axes oriented in all three directions both with the frequency-encoding gradient in the feet-head and right-left directions. The size and pattern of stent-related artifacts were evaluated semiquantitatively for each measurement.
RESULTS: Five different components of artifacts could be distinguished: homogeneous signal reduction inside the stent, narrowing of the stent lumen, structures of various shapes inside the stents, signal reduction or signal increase at the ends of the stents, and shift of the intraluminal signal orthogonal to the longitudinal axis of the vessel. The size of the artifacts depended heavily on the material of the stent. The polyethylene stent showed no artifacts, the tantalum stent only minor artifacts. Nitinol stents were characterized by artifacts at both ends and signal reduction intraluminally. Stents made of steel demonstrated the strongest artifacts, characterized by almost complete signal loss intraluminally. The characteristics of the artifacts of all stents depended on the direction of the stent relative to the frequency-encoding gradient.
CONCLUSIONS: Three-dimensional MRA follow-up after stent placement may be applicable for stent patency evaluation in all instances. However, grading of stenoses seems to be unrealistic in steel stents and in most nitinol stents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283419     DOI: 10.1097/00004424-200104000-00004

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  18 in total

1.  Thoracic aortic stent graft: comparison of contrast-enhanced MR angiography and CT angiography in the follow-up: initial results.

Authors:  Stefanie Weigel; Bernd Tombach; David Maintz; Stefan Klotz; Thomas Vestring; Walter Heindel; Roman Fischbach
Journal:  Eur Radiol       Date:  2003-02-19       Impact factor: 5.315

2.  Comparing different MR angiography strategies of carotid stents in a vascular flow model: toward stent-specific recommendations in MR follow-up.

Authors:  Andreas M J Frölich; Sara M Pilgram-Pastor; Marios N Psychogios; Alexander Mohr; Michael Knauth
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

3.  Feathering: Vertebral artery pseudostenosis with elliptical centric contrast-enhanced MR angiography.

Authors:  J Huston; M A Bernstein; S J Riederer
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

4.  Improved detection of in-stent restenosis by blood pool agent-enhanced, high-resolution, steady-state magnetic resonance angiography.

Authors:  Christina M Plank; Florian Wolf; Herbert Langenberger; Michael Weber; Dietrich Beitzke; Alfred Stadler; Martin Schillinger; Johannes Lammer; Christian Loewe
Journal:  Eur Radiol       Date:  2011-05-10       Impact factor: 5.315

5.  Evaluation of various image reconstruction parameters in lower extremity stents using multidetector-row CT angiography: initial findings.

Authors:  Martin Heuschmid; Benjamin Wiesinger; Gunnar Tepe; Oliver Luz; Andreas F Kopp; Claus D Claussen; Stephan H Duda
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

6.  Carotid stent delivery in an XMR suite: immediate assessment of the physiologic impact of extracranial revascularization.

Authors:  Alastair J Martin; David A Saloner; Timothy P L Roberts; Heidi Roberts; Oliver M Weber; William Dillon; Sean Cullen; Van Halbach; Christopher F Dowd; Randall T Higashida
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

7.  Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.

Authors:  Gitsios Gitsioudis; Philipp Fortner; Matthias Stuber; Anna Missiou; Florian Andre; Oliver J Müller; Hugo A Katus; Grigorios Korosoglou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-17       Impact factor: 2.357

8.  In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla.

Authors:  R Syha; D Ketelsen; M Kaempf; S Mangold; S Sixt; T Zeller; F Springer; F Schick; C D Claussen; K Brechtel
Journal:  Eur Radiol       Date:  2012-08-17       Impact factor: 5.315

9.  Accuracy of multislice CT angiography for the assessment of in-stent restenoses in the iliac arteries at reduced dose: a phantom study.

Authors:  K Perisinakis; E Manousaki; K Zourari; D Tsetis; A Tzedakis; A Papadakis; A Karantanas; J Damilakis
Journal:  Br J Radiol       Date:  2011-03       Impact factor: 3.039

10.  Successful nitinol stent implantation in a large coronary aneurysm: post-interventional patency assessment by magnetic resonance imaging.

Authors:  Frank Breuckmann; Kai Nassenstein; Dirk Boese; Dieter Opherk; Harald H Quick; Jörg Barkhausen; Raimund Erbel
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-04       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.